Several studies have suggested that neurokinin-1 (NK1) receptor antagonists may have therapeutic potential as novel antidepressant drugs. To test these compounds preclinically, gerbils have become one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback